TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at ...

Reports Q4 reported EPS 97c vs. 62c last year. Reports Q4 revenue $14.89B, consensus $14.28B. Pascal Soriot, CEO, AstraZeneca (AZN), ...

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts.

Univar Solutions LLC ("Univar Solutions" or "the Company") announced it has acquired UK-based Brad-Chem Holdings ("Brad-Chem") and its affiliated entities, which includes the acquisition of Brad-Kem, ...